QR kód

Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia

Background: The first-line pharmacologic treatment for both male and female pattern hair loss is topical minoxidil. Nonetheless, off-label usage of low-dose oral minoxidil has demonstrated good clinical efficacy and safety. Objectives: To study the efficacy of oral minoxidil 1.25 mg and 2.5 mg in an...

Celý popis

Uloženo v:
Hlavní autoři: Bhumika Mahawar, Ashish Ramchandra Deshmukh
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2026-01-01
Edice:Dermatologica Sinica
Témata:
androgenetic alopecia
male pattern hair loss
oral minoxidil 1.25 mg
oral minoxidil 2.5 mg
terminal hair count
topical 5%
minoxidil
On-line přístup:https://journals.lww.com/10.4103/ds.DS-D-25-00094
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky